Radiation may reboot immunotherapy in advanced cancer patients
NCT ID NCT06363773
First seen Apr 24, 2026 · Last updated May 14, 2026 · Updated 6 times
Summary
This study tests whether precise, high-dose radiation (stereotactic radiotherapy) can restore the effectiveness of immunotherapy in people with metastatic solid tumors whose cancer had been controlled for at least 6 months but then started growing again. About 35 participants will receive three radiation sessions to one tumor, while continuing immunotherapy. The goal is to see if this approach shrinks not only the treated tumor but also other distant tumors (the abscopal effect).
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for METASTATIC CANCER are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Centre Clinical
RECRUITINGSoyaux, Charente, 16800, France
Conditions
Explore the condition pages connected to this study.